With $20M, UCSD Spinout Jecure To Press New Attack On NASH
Xconomy
FEBRUARY 15, 2017
For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.
Let's personalize your content